Skip to main content

Table 2 Factorial analysis [2 × 2 factorial design (untreated/treated, treatment for 7/28 d)] of IL-6, IL-17, IL-23, TGF-β levels and RORγt, Foxp3 expression between the MDL and DEX groups

From: Pingchuan formula improves asthma via restoration of the Th17/Treg balance in a mouse model

Variation

Indicator

SS

df

MS

F

P

Group (difference between MDL and DEX group)

IL-6

56480.11

1

56480.11

346.92

<0.001

IL-17

10396.43

1

10396.43

118.14

<0.001

IL-23

168584.56

1

168584.56

329.16

<0.001

TGF-β

197694.57

1

197694.57

88.65

<0.001

RORγt

0.45

1

0.45

27.11

<0.001

Foxp3

0.52

1

0.52

66.39

<0.001

Time (difference between 7 d and 28 d treatment)

IL-6

0.11

1

0.11

0.00

0.979

IL-17

1169.06

1

1169.06

13.29

0.001

IL-23

4214.55

1

4214.55

8.23

0.007

TGF-β

21824.31

1

21824.31

9.79

0.003

RORγt

0.04

1

0.04

2.26

0.141

Foxp3

0.01

1

0.01

1.36

0.251

Group *Time

IL-6

220.59

1

220.59

1.36

0.252

IL-17

0.20

1

0.20

0.00

0.962

IL-23

4784.55

1

4784.55

9.34

0.004

TGF-β

25241.88

1

25241.88

11.32

0.002

RORγt

0.01

1

0.01

0.49

0.490

Foxp3

0.00

1

0.00

0.04

0.841

SE

IL-6

5860.97

36

162.81

--

--

IL-17

3167.92

36

88.00

--

--

IL-23

18438.26

36

512.17

--

--

TGF-β

80284.78

36

2230.13

--

--

RORγt

0.59

36

0.02

--

--

Foxp3

0.28

36

0.01

--

--

  1. A P value <0.05 was considered statistically significant
  2. MDL asthma model group without treatment, DEX dexamethasone treated group, IL-6 interleukin-6, IL-17 interleukin-17, IL-23 interleukin-23, TGF-β transforming growth factor-beta, RORγt RAR-related orphan receptor gamma, Foxp3 forkhead box P3**
  3. *Group *Time means that both factor "Group" and "Time" are considered simultaneously